XML 25 R13.htm IDEA: XBRL DOCUMENT v3.24.0.1
INVESTMENTS
12 Months Ended
Dec. 31, 2023
Investments, Debt and Equity Securities [Abstract]  
INVESTMENTS INVESTMENTS
As discussed in Note 2, we have elected to apply the fair value option for FLIAC's entire portfolio of fixed maturity and equity securities and mortgage loans. The impact of the election has resulted in the elimination of a significant portion of the required disclosures for available-for-sale securities and mortgage loans. Disclosures for historical periods under the Predecessor Company are retained at the end of this note under “Predecessor Company”.

See Note 4 for further discussion and disclosures of the fair values of these financial assets.

SUCCESSOR COMPANY

Other Invested Assets

The following table sets forth the composition of “Other invested assets”:
December 31,
20232022
Retained BusinessCeded BusinessTotalRetained BusinessCeded BusinessTotal
 (in millions)
LPs/LLCs:
Equity method:
Private equity$— $$$— $$
Real estate-related— — 
Subtotal equity method— — 
Fair value:
Private equity24 — 24 344 345 
Total LPs/LLCs24 33 344 10 354 
Derivative instruments— 117 117 85 — 85 
Other61 — 61 11 — 11 
Total other invested assets$85 $126 $211 $440 $10 $450 
Accrued Investment Income

The following table sets forth the composition of “Accrued investment income,” as of the date indicated:

December 31,
20232022
Retained BusinessCeded BusinessTotalRetained BusinessCeded BusinessTotal
(in millions)
Fixed maturity securities$48 $$56 $37 $10 $47 
Mortgage loans— — 
Short-term investments and cash equivalents— 
Total accrued investment income$51 $$60 $41 $11 $52 

As of December 31, 2023, the aggregate fair value of mortgage loans that were 90 days or more past due and in non-accrual status was $2 million. The aggregate unpaid principal balance for these loans approximated fair value as of December 31, 2023. As of December 31, 2022, there were no mortgage loans that were 90 days or more past due or in non-accrual status.

There were no write-downs on accrued investment income for the year ended December 31, 2023 or the nine months ended December 31, 2022.

Net Investment Income

The following table sets forth “Net investment income” by investment type, for the periods indicated:

Year Ended December 31, 2023Nine Months Ended December 31, 2022
Retained BusinessCeded BusinessTotalRetained BusinessCeded BusinessTotal
 (in millions)
Fixed maturity securities $221 $51 $272 $123 $94 $217 
Equity securities— — 
Secured receivable— — — — 18 18 
Mortgage loans23 — 23 — 
Other invested assets27 29 
Short-term investments and cash equivalents22 20 42 — 10 10 
Gross investment income$293 $78 $371 $127 $132 $259 
Less: investment expenses (1)(53)(3)(56)(2)(2)(4)
Net investment income$240 $75 $315 $125 $130 $255 

(1) For the year ended December, 31, 2023, investment expenses within the Retained Business includes $33 million of expense related to liabilities associated with repurchase agreements.

The activity in the above chart includes interest income related to fair value option investments, where applicable.
Investment Gains (Losses), Net 

The following table sets forth “Investment gains (losses), net” by investment type, for the periods indicated:

Year Ended December 31, 2023
 Retained BusinessCeded BusinessTotal Business
UnrealizedRealizedTotalUnrealizedRealizedTotalUnrealizedRealizedTotal
(in millions)
Fixed maturity securities$160 $(35)$125 $41 $(22)$19 $201 $(57)$144 
Equity securities— — — — — 
Mortgage loans— — — — — 
Derivatives— (750)(750)— 289 289 — (461)(461)
Total$162 $(785)$(623)$46 $267 $313 $208 $(518)$(310)

Nine Months Ended December 31, 2022
 Retained BusinessCeded BusinessTotal Business
UnrealizedRealizedTotalUnrealizedRealizedTotalUnrealizedRealizedTotal
(in millions)
Fixed maturity securities$(517)$(123)$(640)$232 $(501)$(269)$(285)$(624)$(909)
Equity securities— — — (27)— (27)(27)— (27)
Secured receivable— — — — (59)(59)— (59)(59)
Derivatives— (221)(221)— (691)(691)— (912)(912)
Total$(517)$(344)$(861)$205 $(1,251)$(1,046)$(312)$(1,595)$(1,907)

Repurchase Agreements and Securities Lending Transactions

In the normal course of business, FLIAC sells securities under agreements to repurchase and enters into securities lending transactions.

The following table sets forth, by type, the securities that we have agreed to repurchase, all of which are contained in the Retained Business. The below amounts represent the cash received under the outstanding repurchase agreements.

December 31,
20232022
Remaining Contractual Maturities of the Agreements
Up to 30 days30-90 days1-5 yearsTotalUp to 30 days30-90 daysGreater than 90 daysTotal
U.S. corporate public securities$356 $108 $503 $967 $111 $200 $— $311 
    
The fair value of the securities posted as collateral under the repurchase agreements was $999 million and $326 million as of December 31, 2023 and December 31, 2022, respectively.
The following table sets forth the remaining contractual maturities of the Successor Company's securities lending transactions by the security type that was loaned, all of which are contained in the Ceded Business. The amounts below represent the cash collateral received for the loaned securities.

December 31, 2022
Remaining Contractual Maturities of the Agreements
Overnight & ContinuousUp to 30 days30-90 daysTotal
Equity securities$106 $— $— $106 

There were no outstanding securities lending agreements at December 31, 2023. The fair value of the securities loaned was $103 million as of December 31, 2022.

PREDECESSOR COMPANY

The following table sets forth the sources of proceeds and the associated investment gains (losses) and losses on write-downs related to available-for-sale fixed maturity securities for the Predecessor Company:
Predecessor Company
Three Months Ended March 31
Year Ended December 31
20222021
 (in millions)
Fixed maturity securities, available-for-sale:
Proceeds from sales (1)$294 $8,319 
Proceeds from maturities/prepayments108 828 
Gross investment gains on sales and maturities— 1,413 
Gross investment losses on sales and maturities
(21)(88)
Write-downs recognized in earnings (2)— (23)

(1)Excludes activity from non-cash related proceeds due to the timing of trade settlements of $20.3 million and $253.4 million for the three months ended March 31, 2022 and the year ended December 31, 2021, respectively.
(2)Amounts represent write-downs on securities actively marketed for sale.

Allowance for Credit Losses

There was no change in the allowance for credit losses for fixed maturity securities, available-for-sale, during both the three months ended March 31, 2022 and the year ended December 31, 2021.

The allowance for credit losses for mortgage and other loans declined by $1 million and $2 million during the three months ended March 31, 2022 and the year ended December 31, 2021, respectively. The decrease in each period related to the improving credit environment.
Net Investment Income

The following table sets forth “Net investment income” by investment type for the periods indicated:
Predecessor Company
Three Months Ended March 31Year Ended December 31
20222021
 (in millions)
Fixed maturity securities (1)$61 $383 
Equity securities
Commercial mortgage and other loans11 65 
Other invested assets29 63 
Short-term investments and cash equivalents
Gross investment income103 517 
Less: investment expenses(4)(27)
Net investment income$99 $490 

(1)Includes fixed maturity securities classified as available-for-sale and trading by the Predecessor Company.

Investment Gains, Net 

The following table sets forth “Investment gains, net” by investment type for the periods indicated:
Predecessor Company
Three Months Ended March 31Year Ended December 31
20222021
 (in millions)
Fixed maturity securities (1)$(21)$1,302 
Mortgage and other loans— 53 
Derivatives (2)502 6,124 
Other invested assets— 10 
Investment gains, net$481 $7,489 

(1)Includes fixed maturity securities classified by the Predecessor Company as available-for-sale and excludes fixed maturity securities classified by the Predecessor Company as trading.
(2)Includes the impact of the 2021 Variable Annuities Recapture. See Note 8 for additional information.